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Abstract 
Background: High-flow nasal cannula (HFNC) is a type of non-invasive respiratory support that 
has decreased the rate of intubation in infants and children. It is utilized in the PICU and the 
wards. Due to the increased volume of patients on HFNC, a standard HFNC weaning protocol 
was created to improve the management of these patients.  
Methods: Potential patients were identified through the Virtual Pediatric System (VPS) with the 
criteria of ages 1 month to 6 years old, admitted to the PICU during the months of January to 
March of 2018 and 2019, with diagnosis of bronchiolitis and requiring HFNC. Chart review was 
then conducted to eliminate the patients that did not meet the inclusion criteria. There were 48 
patients in the pre-protocol group and 70 patients in the post protocol group. Further chart review 
was conducted to gather the information on the 2 groups. 
Results: Using independent t-test comparing the pre- and post-weaning protocol groups showed 
no significant differences between the pre- and post-protocol groups in PICU length of stay 
(2.3±1.8 vs 2.1±2.1d),  hospital length of stay (4.8±2.2 vs 4.2±1.6d ), and duration of HFNC use  
(87.4±47 vs 74.2±37.4 hr). The magnitude of difference in the means of the hospital length of 
stay and PICU length of stay were small (eta squared=0.02; 0.002 respectively). 
 
 
 
Key words: Bronchiolitis; weaning; protocol; HFNC; RSV; infants; children; pediatric; hospital 
length of stay; PICU length of stay 
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The Effect of High Flow Nasal Cannula Weaning Protocol on Decreasing Length of Stay in 
Pediatric Intensive Care 
Bronchiolitis in infants and young children is one of the most common reasons for 
admission to the hospital as it causes lower respiratory infections (McKiernan, Chua, Visintainer, 
& Allen, 2010). Symptoms of bronchiolitis include increased work of breathing, cough, 
rhinorrhea, tachypnea, tachycardia, fever, wheeze, and hypoxia related to bronchiole obstruction 
due to mucus plugging and edema (McKiernan et al., 2010). The management of bronchiolitis 
involves solely supportive care which can include respiratory support, IV hydration, and comfort 
measures (Hanlon, 2014).  
High-flow nasal cannula (HFNC) is a method of non-invasive respiratory support that 
delivers heated high flow via nasal cannula providing continuous positive airway pressure and 
having the option to increase or decrease oxygen concentration (McKiernan et al., 2010). HFNC 
tends to be well-tolerated in infants and children, decreasing the need for sedation, and most 
likely decreasing the rate for invasive mechanical ventilation (McKiernan et al., 2010).  
At Norton Children’s Hospital, weaning of HFNC liter flow was dependent on the 
decision of healthcare providers (physician, resident, and/or nurse practitioner) caring for the 
patient which could be delayed due to unexpected interruptions. A multidisciplinary team created 
a weaning protocol for the patients on the wards and this was extended to the PICU. With the use 
of a weaning protocol by both the PICU and wards, the hope that this will lead to fewer PICU 
and hospital days. With the use of the HFNC protocol, one would hypothesize a decrease in the 
time on HFNC.  
A literature review was conducted determine if there are any standard use protocols for 
HFNC for infants and children in the Pediatric Intensive Care and Medical-Surgical floors.  
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The literature review was performed using CINAHL, Cochrane, National Guidelines 
Clearinghouse and MEDLINE with the following keywords: high-flow nasal cannula, 
bronchiolitis, weaning, pediatric intensive care, infants, and children. Limitations in this review 
include literature published from 2010-2017, in English, children ages 0-18, and hospital-based 
studies. Fifteen articles were reviewed and of those 15 articles, seven were retrospective 
studies, five prospective studies, and three literature reviews (See Appendix A). The seven 
retrospective studies include two that evaluated the efficacy of the HFNC by comparing pre-
HFNC and post-HFNC in the PICU (Kawaguchi, Yasui, deCaen, & Garros, 2017; McKiernan et al., 
2010) and one study compared the use of CPAP verses the use of HFNC (Metge et al., 2014). 
Two of the studies compared the use of HFNC in the PICU and in the wards (Goh, Kirby, Schell, 
& Egan, 2017; Riese, Fierce, Riese, & Alverson, 2015) and two evaluated the use of HFNC in the 
PICU (Coletti, Bagdure, Walker, Remy, & Custer, 2017; Wraight & Ganu, 2015). Of the five 
prospective studies, one study created and evaluated a “holiday” based weaning protocol 
(Betters et al., 2017), two evaluated the effect of different flow rates on the effect of breathing 
(Hough, Pham, & Schibler, 2014; Weiler et al., 2017), and two evaluated the efficiency of 
oxygen therapy via HFNC (Bressan et al., 2013; Oto, Erdoğan, & Boşnak, 2016). Two of the three 
articles that were reviewed examined the mechanisms of action, effectiveness, safety, 
tolerance, and complications of HFNC with the reviews providing evidence of the safety, 
efficacy, and well-tolerated HFNC (Hutchings, Hilliard, & Davis, 2015; Mikalsen, Davis, & Øymar, 
2016), while the third literature review searched for protocols to wean or discontinue HFNC in 
preterm infants with the conclusion there is an absence of protocols and further studies are 
needed to provide evidence for practice (Farley, Hough, & Jardine, 2015).  
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With the wide use of HFNC in the PICU, the use of HFNC has expanded to the pediatric 
wards at some institutions as a means of respiratory support. Several retrospective studies 
examined the use of HFNC in the PICU before and after introduction to the pediatric wards (Goh 
et al., 2017; Riese et al., 2015). Although starting HFNC on the pediatric wards did not decrease 
the rate of PICU admission, the use of HFNC did lead to a decrease in need for intubation and 
length of hospital stay (Goh et al., 2017; Riese et al., 2015). Another prospective observational 
study examined the introduction of HFNC on the pediatric wards and evaluated patients less than 
12 months old admitted for moderate to severe bronchiolitis (Bressan et al., 2013). Twenty-seven 
patients were enrolled and placed on HFNC; all patients saw an improvement in respiratory rate 
and ETCO2; none of the twenty-seven patients required PICU admission (Bressan et al., 2013). 
The literature review search resulted in a single study evaluating a weaning protocol and 
a 2015 Cochrane review for weaning protocols for pre-term infants. This Cochrane review was 
conducted examining available literature regarding weaning strategies for infants on HFNC 
(Farley et al., 2015). The review included randomized control studies, quasi-RCT, and any 
weaning protocols searching up to the year 2015, but was unable to find any studies meeting the 
inclusion criteria (Farley et al., 2015). The authors stated the need for specific criteria to define 
what parameters would constitute the time to wean HFNC and what defines failure to wean 
HFNC (Farley et al., 2015). 
Since the Cochrane review was completed in 2015, one single center study created a 
“holiday” protocol for the PICU using a Respiratory Assessment Score (RAS) to evaluate the 
readiness of the patient for weaning from HFNC (Betters et al., 2017). The HFNC holiday 
protocol is based on the RAS scores which will determine if the patient remains on the same 
flow rate, decrease flow rate by half, or transition to conventional nasal cannula. Of the 133 
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patients in the study, 119 patients were successfully weaned off HFNC to low flow nasal cannula 
with 83 patients weaned in the first attempt, 26 patients with the second attempt, nine patients 
with the third attempt, and one patient weaned in four attempts (Betters et al., 2017). None of the 
36 patients who were weaned after several attempts require escalation of respiratory support. The 
RAS was created from a combination of the Wood-Downes score and Silverman-Andersen 
Respiratory Distress Index with scores ranging from 0-2 in six categories with a potential total 
score of 12 points. Respiratory therapists (RTs) screened the patients twice a day with the use of 
RAS to determine if the patient qualified for a “holiday” off HFNC. Scores of six or less 
qualified for a “holiday,” scores of 7-8 prompted a decrease in the flow rate by half, and scores 
greater than eight had no direct change. They also examined the  PICU LOS (5 vs 21 days; 
p<0.0001) and total hospital LOS (9 vs 28.5 days; p<0.001) and both LOS were lower in the 
successful weaning group as compared to the unsuccessful weaning group (Betters et al., 2017). 
This study was the first to examine a protocol for weaning HFNC and showed it was efficient, 
timely, and safe.  
Hutchings, Hilliard, and Davis (2015) discussed the development of guidelines of HFNC 
management in their institution and the use of the Pediatric Early Warning (PEW) Score as an 
indication to escalate or wean the HFNC. An algorithm was created to develop guidelines in the 
management of HFNC and the timing of transferring a patient to the PICU (Hutchings et al., 
2015). Initial FIO2 was set at 40 % and the flow was set dependent on age. However, the authors 
did not discuss the timing, success or failure of the guidelines. 
Theoretical Framework  
Donabedian’s health care quality model is a framework designed to evaluate the quality 
of health care (See Appendix D). The Donabedian’s model has three categories which include 
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structure, process, and outcome (Donabedian, 1988). The structure is the setting in which health 
care is provided. This may include a facility, equipment, providers, and patients. The process is 
the operations between patients and providers that occur throughout the healthcare delivery. The 
process ranges from diagnosis to preventive intervention to treatment. The outcome is the effects 
of healthcare on patients’ health. This model is perfect for the quality improvement study of 
evaluating the HFNC weaning protocol.  
Setting and Organizational Assessment 
Data were reviewed during 3-month periods of January to March 2018 (pre-protocol) and 
January to March 2019 (post protocol) at Norton Children’s Hospital PICU. The Children’s 
Hospital has a 300-bed capacity with PICU having 36-bed unit serving the tri-state area 
(Kentucky, Indiana, and Ohio). 
Purpose 
The use of HFNC is increasing in the hospital setting, including the wards, ED, and 
PICU. With the increased use of HFNC, the implementation of a standard weaning protocol that 
can be used for infant and children in any inpatient hospital setting could potentially improve 
multiple child outcomes. The hypothesis is that the use of a standardized HFNC protocol would 
decrease the length of stay in the PICU, hospital length of stay, and length of time on HFNC. 
With the decrease in length of stay, this would lead to improved child outcomes and decreased 
healthcare costs to the family.  
 This study compared data from infants and children three months (January-March 2018) 
prior to the initiation of the HFNC weaning protocol with infants and children during the same 
three months (January-March 2019) post-initiation of the protocol examining the LOS in PICU, 
hospital LOS, adverse events, and length of HFNC use. During the winter and spring months, 
11 
HFNC WEANING PROTOCOL 
our institution has the highest frequency of admissions for bronchiolitis. The Children’s Hospital 
wards have implemented a weaning protocol that is accessible in EPIC, which is our electronic 
medical record system (see Appendix C).  This protocol was used in the PICU and continued 
with the transfer of the patient to the wards. 
Intervention 
The HFNC weaning protocol was implemented in the PICU in January-March 2019. The 
HFNC weaning protocol order set is present in EPIC (See Appendix C). The weaning protocol 
was initiated when the patient required oxygen of 40% or less, with saturations greater than 90 
%, and respiratory rate less than 60 breaths per minute for infants one-month to one-year old, 
less than 40 breaths per minute for one-to-two-year-old, and less than 30 breaths per minute for 
three- to six-year-old children. The protocol was implemented by the RTs. Once the PICU 
patient was on HFNC settings appropriate for the ward, the patient was transferred to the 
pediatric wards and continued with the weaning protocol. The purpose of the project was to 
examine the impact of standard HFNC weaning protocol on infants and children with 
bronchiolitis ages one-month to six-years and shortening PICU LOS and hospital LOS, when 
compared to those infants and children who did not receive the weaning protocol.  
The quality improvement project was sent to the IRB for approval but was exempt. A 
retrospective chart review was conducted to identify patients not placed on the HFNC weaning 
protocol during the months of January to March 2018, for comparison with the data obtained 
from patients placed on the HFNC weaning protocol during the months of January to March 
2019.  
Participants 
12 
HFNC WEANING PROTOCOL 
The participants were children admitted to the PICU at Norton Children’s Hospital 
requiring HFNC support. The inclusion criteria were patients who were one-month to six-years, 
diagnosed with bronchiolitis via clinical or viral confirmation, admitted to the PICU, and 
requiring HFNC. The exclusion criteria were patients with diagnosis of status asthmaticus 
requiring continuous albuterol, superimposed pneumonia demonstrated on chest x-ray, and an 
additional history of chronic lung disease, neuromuscular disorders, and/or congenital heart 
disease. 
Data Collection  
Virtual Pediatric System (VPS) which is a PICU comparative database used nationally 
and internationally comparing the individual PICU data to other PICUs was used to search for 
potential patients meeting the criteria. Data were collected using the Epic Electronic Medical 
Record (EMR) system during the months of January to March 2018, for comparison with the 
data obtained from patients placed on the HFNC weaning protocol during the months of January 
to March 2019. Demographic characteristics, insurance, admission, transfer, and discharge dates, 
and past medical history, were collected using EMR. The patients’ symptoms, vital signs, 
laboratory tests, and medications were obtained along with length of time on HFNC, highest and 
lowest HFNC settings, complications, and readmission to PICU within 24 hours of transfer.  
Measurement 
Multiple discussions were had with several PICU attendings to assess what information 
would be beneficial to collect. The following data were deemed important to collect. 
Demographic data collected included gender, ethnicity, insurance, age, and prematurity. Hospital 
course data included admission, transfer, discharge dates, interval times on HFNC to time off 
HFNC, and time weaning order placed. Vital signs collected included heart rate, respiratory rate, 
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and saturations at initiation of HFNC and at one-hour post HFNC initiation. Additional tests 
assessed included chest x-ray, blood, urine, and spinal fluid cultures, and respiratory panel. 
Additional therapies utilized included antibiotics, breathing treatments, steroids, and fluids. 
Complications of significance included escalation of respiratory support or development of 
pneumothorax (See Appendix B). The data that were missing pertained to vital signs and this 
was addressed in the SPSS.  
Results 
 SPSS 25 statistical software was used to analyzed the data. The sample included 48 
patients (26 males; 54.1 %) in the pre-protocol group versus 70 (39 males; 55.7 %)) in the post-
protocol group. Ages range from one month to 37 months (mean 7.6 mo and SD 7.57). Ethnicity 
results were 70 % white, 20 % African American, and 17 % Hispanic. In regards to insurance, 39 
% with private insurance and 59 % had government insurance (See Table 1). Twenty-four 
percent were born premature (<37 weeks) with 15 patients in the pre-protocol and 13 patients in 
the post-protocol groups. Forty-three percent of patients tested positive for RSV, 9% tested 
positive for Rhino/Enterovirus, 21 % tested positive for multiple viruses, 14 % tested positive for 
other viruses, 3 % tested negative, and 10 % were not tested (Table 5). 
 The independent t-test was used to compare the pre-post weaning protocol groups. The 
results showed no significant differences between the pre- and post-protocol groups in PICU 
length of stay (2.3±1.8 vs 2.1±2.1d; t(116)=0.52, p<0.603, two-tailed), hospital length of stay 
(4.8±2.2 vs 4.2±1.6d; t(116)=1.66, p<0.098 two-tailed), and duration of HFNC use (87.4±47 vs 
74.2±37.4 hr; t(116)=1.69, p<0.093 two-tailed).  The magnitude of difference in the means of the 
PICU length of stay (mean difference=0.15, 95 % CI: -0.42 to 0.71), hospital length of stay 
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(mean=0.59, 95% CI: -0.11 to 1.29), and length of time on HFNC (mean difference= 13.19, 95% 
CI: -2.25 to 28.64) were small (eta squared=0.02; 0.002; 0.02 respectively) (See Table 2).  
Discussion 
Interpretation 
   The results showed no significant difference of PICU length of stay and hospital 
between the pre-post protocol groups (p<0.603 and p<0.098, respectively). The results 
counteract what Betters et al. (2017) discovered when they implemented a HFNC weaning 
protocol at their institution and reported a significant difference in PICU LOS between the group 
(n=119) successful with the weaning protocol and the group (n=14) who failed the weaning 
protocol (median 9 vs 21 d; p<0.001) and hospital LOS (median 9 vs 28.5; p<0.001). The 
difference in results reflect the different parameters used as they compared the successful group 
to the unsuccessful group whereas this author compared anyone placed on the protocol making 
the comparisons between the two studies unequals. The protocol they created was in the form of 
“holiday” as opposed to primarily weaning in specific time frame. The patients in the 2 groups 
had a variety of diagnoses included asthma, bronchiolitis, trauma, pneumonia, and postoperative 
which are difficult to compare due to the progression of the disease process. Those patients who 
failed the weaning protocol were complicated postoperative patients including liver and bone 
marrow transplants. Riese et al. (2015) saw a reduction in hospital LOS after initiation of HFNC 
on the general pediatric wards (median 4 vs 3 d; p<0.001) and a decrease in HGNC length of 
time from 2.4 days to 1.8 days. Goh et al (2017) also found a reduction in PICU LOS and 
hospital LOS once HFNC was utilized on the general pediatric wards (median 2.2 d and 6 d 
respectively). In the current study, there was no significant difference in HFNC length of time 
between the pre-post protocol groups (p<0.093). The non-significant difference could be related 
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to the small sample sizes and unequal groups with pre-protocol group of 48 patients and post-
protocol group of 70 patients. Other factors that could have affected the results are the 
compliance of following the protocol, the lack of timeliness in ordering the protocol, or lack of 
ordering the protocol. These factors could be related to the fact that the protocol was new to the 
PICU and with that there may be educational lacking with the RTs and healthcare providers.   
 The implementation of the HFNC weaning protocol remains an excellent way to utilize 
the Respiratory Therapists’ (RT) skills and give them autonomy in respiratory care practice and 
patient care. The HFNC weaning protocol gives professional ownership to RTs and takes the 
sole responsibility from the healthcare providers who often have other distractions during the day 
that may delay their ability to reassess the patients and wean HFNC as often as possible. Betters 
et al., (2017) demonstrated that with the implementation of a HFNC weaning protocol it was 
safe, timely, and efficient but also acknowledge the need for further studies with the use of 
weaning protocol of larger population to determine the effectiveness of the weaning protocol on 
PICU and hospital LOS.  
 As of now, at our hospital, the RTs are the only healthcare professionals to be able to 
wean the flow rate. The bedside nurses are allowed to wean the oxygen. If the bedside nurses 
were allowed to wean the flow, then the HFNC weaning protocol would be better utilized as both 
nurses and RTs would assess the patient at different times which would promote consistency 
with the weaning process. Betters et al., (2017) documented the use of RTs in using the weaning 
protocol but made mentioned that the RTS were the only ones who were knowledgeable with the 
scoring system created. With the potential for improved HFNC weaning procedures, then this 
could lead to improved patient outcomes. 
Limitations 
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 The limitations with this project include a small sample size which could lead to non-
significant results and not represent the population well. The inconsistency of following the 
HFNC weaning protocol by the RTs due to the busyness of the unit or delay in recognition of the 
HFNC order placed could negatively influence patient outcomes. The timing of placing the 
HFNC weaning protocol could be delayed due to multiple admissions or busyness of the unit. 
The healthcare providers may not be aware of the HFNC weaning protocol. 
Conclusion 
The HFNC weaning protocol has great potential but consistency in physicians ordering 
the protocol and RTs following the protocol remains potentially lacking. The results of the 
project were insignificant but represented a small mean decrease in the post-protocol groups 
concerning pediatric ICU and hospital length of stay and hours on HFNC. There needs to be a 
change in the implementation of the HFNC weaning protocol such as including the weaning 
protocol in place on admission to allow the RTs to use at their discretion. Also, it is important to 
investigate if a bedside nursing practice change with nursing is feasible by contacting the Board 
of Nursing and Norton Children’s Hospital. With the input of both nursing and RTs, the use of 
HFNC weaning protocol would be maximized and more consistent implementation of the 
protocol and following the protocol would occur to improve patient outcomes.   
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Appendix A 
  
 
 
 
 
 
 
Abbreviations 
HFNC-high flow nasal cannula; PICU-pediatric intensive care unit; pts-patients; EMR-electronic medical record; 
dx-diagnosis; wt-weight; resp-respiratory; assess-assessment; hrs-hours; LOS-length of stay; RT-respiratory 
therapist; HR-heart rate; RR-respiratory rate; WOB; work of breathing; nCPAP-nasal continuous positive airway 
pressure; mos-months; yrs-years; NIV-non-invasive ventilation; MV-mechanical ventilation 
 
  
 
 
 
 
 
Citation Findings 
Farley et al, 
2015 
No studies met the criteria for protocols weaning of HFNC in preterm 
infants 
Metge et al, 
2014 
No difference between using nCPAP (19 pt) and HFNC (15 pts) 
Weaning: started when FiO2<25 %, PCO2<45 mmHg;  
Coletti et al, 
2017 
HFNC utilization on variety of dx (asthma, bronchiolitis, CHD) 
Majority of pts <12 yrs; 10 % of pts (NIV) or intubation;  
McKiernan et 
al, 2010 
68 % decrease in need for intubation with the use of HFNC; pts on HFNC 
had improvement within 1 hour of initiating HFNC 
Riese et al, 2015 Decreased LOS with ward protocol; weaning HFNC faster on wards vs 
PICU; 30 % of PICU pts transferred to floor on HFNC 
Wraight et al, 
2015 
42 pts (78%) on HFNC did not require intubation; 7 pts required CPAP; 5 
were intubated; 75% of patients failed within 8 hours  
Goh et al, 2017 No difference in PICU admits from wards with HFNC on wards; Decrease 
need for intubation and hospital LOS; Did not require higher than 2 
L/kg/min 
Kawaguchi et 
al, 2017 
HFNC group less likely to be intubated; shorter Mechanical ventilation 
days; longer PICU LOS;  
Betters et al, 
2017 
119 of 133 pts weaned off HFNC (85%); median duration of 15 hrs; PICU 
LOS lower (5vs21, p<0.001)  
Weiler et al, 
2017 
Increase in flow rates decreased WOB, with most effective at 1.5-
2L/kg/min; and greater in pts <8kg 
Oto et al, 2016 40 of the 50-pts improved on HFNC while 10 pts required intubated; 
improvement seen on HFNC at 30 minutes/12 hrs;  
Hough et al, 
2014 
Increased in end-expiratory lung volume with higher HFNC of 8L/min; 
improved respiratory status; decreased FiO2 needs 
Bressan et al, 
2013 
HFNC used improved saturations, work of breathing; optimal option for pts 
with bronchiolitis; safe use on wards 
Mikalsen et al, 
2016 
HFNC safe, well-tolerated; increased PEEP, improve pulmonary 
compliance 
Hutchings et al, 
2015 
PEW scores used for escalation/weaning of HFNC, flow rate dependent on 
age, start at 40 % FiO2, algorithm for escalation  
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Data Collection Sheet 
Age(months)  Treatment in ED  Treatment in PICU:  
Sex  Albuterol  IVFs  
Ethnicity  Steroids  Dietary  
Insurance  ABX  Steroids  
Weight(kg)  Fluid Hydration  Albuterol  
Allergies    Mucolytic  
Admit last 30 days  Prematurity (<37 weeks)  Antibiotics  
  Syndrome/Genetic    
ED admit date  RAD/CLD  Complications-BiPAP  
PICU admit date  FTT  Intubate  
Transfer floor date    Pneumothorax  
D/C home date  Labs: CXR    
Bounce back within 24 hours  Respiratory Panel  Initial Time placed on HFNC  
  Blood culture  Time of order placed  
Initial HFNC 
Heart Rate 
 Urine Culture  Time of 1st wean  
Respiratory Rate  Lumbar puncture  Time removed from HFNC  
Saturations    Highest Flow  
HFNC-Liters  # days of symptoms  Highest FiO2  
HFNC-FiO2  Rhinorrhea  Lowest Flow  
  Fever  Lowest FiO2  
1 hr. post HFNC initiation 
Heart Rate 
 Cough  Respiratory support at time of 
transfer to floor-HFNC; NC; RA 
 
Respiratory Rate  Congestion    
Saturations  Decreased PO intake    
HFNC-Liters  Increased WOB    
HFNC-FiO2      
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HFNC Weaning Order Protocol 
Patient less than 12 months of age  Patient 12 months or greater  
 
 RT to evaluate every 4 hours  RT to evaluate every 4 hours 
 Wean HFNC every 4 hours  Wean HFNC every 4 hours 
 Wean by 1 LPM  Wean by 1-2 LPM 
 Respiratory rate <60  Respiratory rate <30-40 
 Minimal retractions/accessary muscle use: no 
retractions or only mild subcostal or 
intercostal retractions 
 Minimal retractions/accessary muscle use: no retractions 
or only mild subcostal or intercostal retractions 
 Goal 3 LPM and 25 % to transition to nasal 
cannula 
 Goal 5 LPM and 25 % to transition to nasal cannula 
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The Donabedian Model 
 
 
 
 
 
 
Lighter, D. E. (2015). How (and why) do quality improvement professionals measure performance?. International 
Journal of Pediatrics and Adolescent Medicine, 2(1), 7-11. 
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Table 1 
 
Demographics 
 
Demographic Variables N (%) 
 
Gender-  Male 
               Female 
 
65 (55.1) 
53 (44.9) 
Ethnicity- White  
                 African American 
                 Hispanic 
                 Other  
 
83 (70.3) 
23 (19.5) 
  8 (16.8) 
  4 (3.4) 
Insurance-  Private 
                   Government 
                   Unknown 
46 (39) 
70 (59.3) 
  2 (1.7) 
 
N = 118 
 
 
 
 
 
 
 
Table 2 
 
Independent t-tests comparison of pre-post weaning groups 
 
Variable Groups 
 
Mean ± SD t dƒ ƿ 
PICU LOS 
      Pre-Protocol(n=48) 
 
      Post-Protocol(n=70) 
 
2.3±1.8d 
 
2.1±2.1d 
 
 
0.52 
 
116 
 
0.603 
Hospital LOS 
       Pre-Protocol(n=48) 
 
       Post-Protocol(n=70) 
 
 
4.8±2.2d 
 
4.2±1.6d 
 
1.66 
 
116 
 
0.098 
HFNC Length of time 
       Pre-Protocol(n=48) 
 
       Post-Protocol(n=70) 
 
87.4±47hr 
 
74.2±37.4hr 
 
1.69 
 
116 
 
0.093 
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Table 3 
 
Age/weight 
 
Age       1 month-37 months (M=7.4 mo; SD=2.7) 
 
Weight      2.8-16.6 kg (M=7.4 kg; SD=2.7) 
 
 
Table 4 
Prematurity 
 
Prematurity N (%) 
No 90 (76.3) 
Yes 28 (23.7) 
 
 
 
 
 
 
Table 5 
 
Viruses 
 
Viruses N (%) 
   RSV 51 (43) 
   Rhino/Enterovirus 11 (9) 
   Other 16 (14) 
   Multiple Viruses 25 (21) 
   Negative Test 3 (3) 
   No Test 12 (10) 
 
 
